Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,678,621
+$2,318,072 QoQ
Shares Held
10,547
+615.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,087
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $32,931,118 across 11 Drug Manufacturers - General names. JNJ ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,566 | $17,470,898 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,360 | $4,672,260 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,547 | $2,678,621 | |
| 4 | AMGN |
Amgen Inc
|
6,520 | $2,361,022 | |
| 5 | ABBV |
AbbVie Inc.
|
8,651 | $2,176,937 | |
| 6 | AZN |
Astrazeneca PLC
|
7,518 | $1,425,563 | |
| 7 | BIIB |
Biogen Inc.
|
2,701 | $583,578 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,405 | $556,527 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,678,621 | 10,547 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $360,549 | 1,475 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $298,008 | 1,440 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $299,638 | 1,616 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,414,923 | 9,263 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,459,060 | 8,798 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,885,313 | 19,951 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,650,815 | 16,357 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,773,824 | 18,978 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,373,876 | 21,328 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,315,051 | 21,150 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,285,857 | 21,097 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $3,441,326 | 20,791 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,211,755 | 20,721 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,624,842 | 14,859 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,357,284 | 14,430 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,633,005 | 14,833 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,559,201 | 14,440 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,666,468 | 15,587 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,533,773 | 15,689 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,680,978 | 16,274 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,614,808 | 15,910 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,268,003 | 14,411 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,169,628 | 14,573 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,038,150 | 14,493 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,823,493 | 13,906 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||